Drug search by name
Mogamulizumab-kpkc Intravenous and Retacrit
Determining the interaction of Mogamulizumab-kpkc Intravenous and Retacrit and the possibility of their joint administration.
Check result:
Mogamulizumab-kpkc Intravenous <> Retacrit
Relevance: 23.02.2023
Reviewer: Shkutko P.M., M.D., in
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Mogamulizumab-kpkc Intravenous
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
Retacrit
Generic Name: epoetin alfa
Brand name: Epogen, Procrit, Retacrit
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
The list of popular interactions
- Mogamulizumab-kpkc Intravenous-Retapamulin
- Mogamulizumab-kpkc Intravenous-Retapamulin topical
- Mogamulizumab-kpkc Intravenous-Retapamulin Topical application
- Mogamulizumab-kpkc Intravenous-Retavase
- Mogamulizumab-kpkc Intravenous-Retavase Half-Kit
- Mogamulizumab-kpkc Intravenous-Reteplase
- Retacrit-Molindone
- Retacrit-Mometasone (Oral Inhalation)
- Retacrit-Mometasone and Formoterol
- Retacrit-Mometasone and formoterol Inhalation
- Retacrit-Mometasone Cream
- Retacrit-Mometasone Furoate
Doktika World
Interaction with food and lifestyle
Disease interaction